Peptide-Based Approaches to Directly Target Alpha-Synuclein in Parkinson’s Disease

The authors describe and summarize the current efforts made in the development of peptides and their mimetics to directly engage with alpha-synuclein with the intention of modulating aggregation, and importantly, toxicity.